Market Executive Summary
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Due to the COVID-19 pandemic, the global Contract Pharmaceutical Manufacturing market size was US$ 87350 million in 2022 and is forecast to a readjusted size of US$ 131100 million by 2029 with a CAGR of 5.9% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Oral accounting for % of the Contract Pharmaceutical Manufacturing global market in 2022, is projected to value US$ million by 2029, growing at a revised ?GR from 2023 to 2029. While Large Enterprise segment is altered to an ?GR throughout this forecast period.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Contract Pharmaceutical Manufacturing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Contract Pharmaceutical Manufacturing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Contract Pharmaceutical Manufacturing market. Readers of the report can become informed about current and future trends of the global Contract Pharmaceutical Manufacturing market and how they will impact market growth during the forecast period.
By Company
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Segment by Type
Oral
Injectable
API
Other
Segment by Application
Large Enterprise
Small Medium Enterprise
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Contract Pharmaceutical Manufacturing in global and regional level.
Chapter 3: Detailed analysis of Contract Pharmaceutical Manufacturing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Pharmaceutical Manufacturing revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Contract Pharmaceutical Manufacturing Market Growth Rate by Application: 2018 VS 2022 VS 2029
1.3.2 Large Enterprise
1.3.3 Small Medium Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Contract Pharmaceutical Manufacturing Market Size (2018-2029)
2.2 Contract Pharmaceutical Manufacturing Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029
2.3 Global Contract Pharmaceutical Manufacturing Market Size by Region (2018-2023)
2.4 Global Contract Pharmaceutical Manufacturing Market Size Forecast by Region (2024-2029)
2.5 Global Top 10 Contract Pharmaceutical Manufacturing Countries Ranking by Market Size
3 Contract Pharmaceutical Manufacturing Competitive by Company
3.1 Global Contract Pharmaceutical Manufacturing Revenue by Players
3.1.1 Global Contract Pharmaceutical Manufacturing Revenue by Players (2018-2023)
3.1.2 Global Contract Pharmaceutical Manufacturing Market Share by Players (2018-2023)
3.2 Global Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Contract Pharmaceutical Manufacturing Revenue
3.4 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio
3.4.1 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contract Pharmaceutical Manufacturing Revenue in 2022
3.5 Global Key Players of Contract Pharmaceutical Manufacturing Head office and Area Served
3.6 Global Key Players of Contract Pharmaceutical Manufacturing, Product and Application
3.7 Global Key Players of Contract Pharmaceutical Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Contract Pharmaceutical Manufacturing Breakdown Data by Type
4.1 Global Contract Pharmaceutical Manufacturing Historic Revenue by Type (2018-2023)
4.2 Global Contract Pharmaceutical Manufacturing Forecasted Revenue by Type (2024-2029)
5 Global Contract Pharmaceutical Manufacturing Breakdown Data by Application
5.1 Global Contract Pharmaceutical Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023)
6.2 North America Contract Pharmaceutical Manufacturing Revenue by Type (2018-2029)
6.3 North America Contract Pharmaceutical Manufacturing Revenue by Application (2018-2029)
6.4 North America Contract Pharmaceutical Manufacturing Revenue by Country (2018-2029)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023)
7.2 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2018-2029)
7.3 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2018-2029)
7.4 Europe Contract Pharmaceutical Manufacturing Revenue by Country (2018-2029)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023)
8.2 Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2018-2029)
8.3 Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2018-2029)
8.4 Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2018-2029)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023)
9.2 Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2018-2029)
9.3 Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2018-2029)
9.4 Latin America Contract Pharmaceutical Manufacturing Revenue by Country (2018-2029)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023)
10.2 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2018-2029)
10.3 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2018-2029)
10.4 Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2018-2029)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Contract Pharmaceutical Manufacturing Products and Services
11.1.4 Catalent Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.1.5 Catalent Contract Pharmaceutical Manufacturing SWOT Analysis
11.1.6 Catalent Recent Development
11.2 DPx
11.2.1 DPx Company Details
11.2.2 DPx Business Overview
11.2.3 DPx Contract Pharmaceutical Manufacturing Products and Services
11.2.4 DPx Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.2.5 DPx Contract Pharmaceutical Manufacturing SWOT Analysis
11.2.6 DPx Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Contract Pharmaceutical Manufacturing Products and Services
11.3.4 Lonza Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.3.5 Lonza Contract Pharmaceutical Manufacturing SWOT Analysis
11.3.6 Lonza Recent Development
11.4 Piramal Healthcare
11.4.1 Piramal Healthcare Company Details
11.4.2 Piramal Healthcare Business Overview
11.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Products and Services
11.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.4.5 Piramal Healthcare Contract Pharmaceutical Manufacturing SWOT Analysis
11.4.6 Piramal Healthcare Recent Development
11.5 Aenova
11.5.1 Aenova Company Details
11.5.2 Aenova Business Overview
11.5.3 Aenova Contract Pharmaceutical Manufacturing Products and Services
11.5.4 Aenova Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.5.5 Aenova Contract Pharmaceutical Manufacturing SWOT Analysis
11.5.6 Aenova Recent Development
11.6 Jubilant
11.6.1 Jubilant Company Details
11.6.2 Jubilant Business Overview
11.6.3 Jubilant Contract Pharmaceutical Manufacturing Products and Services
11.6.4 Jubilant Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.6.5 Jubilant Contract Pharmaceutical Manufacturing SWOT Analysis
11.6.6 Jubilant Recent Development
11.7 Famar
11.7.1 Famar Company Details
11.7.2 Famar Business Overview
11.7.3 Famar Contract Pharmaceutical Manufacturing Products and Services
11.7.4 Famar Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.7.5 Famar Contract Pharmaceutical Manufacturing SWOT Analysis
11.7.6 Famar Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products and Services
11.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.8.5 Boehringer Ingelheim Contract Pharmaceutical Manufacturing SWOT Analysis
11.8.6 Boehringer Ingelheim Recent Development
11.9 Fareva Holding
11.9.1 Fareva Holding Company Details
11.9.2 Fareva Holding Business Overview
11.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Products and Services
11.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.9.5 Fareva Holding Contract Pharmaceutical Manufacturing SWOT Analysis
11.9.6 Fareva Holding Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Contract Pharmaceutical Manufacturing Products and Services
11.10.4 AbbVie Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.10.5 AbbVie Contract Pharmaceutical Manufacturing SWOT Analysis
11.10.6 AbbVie Recent Development
11.11 Nipro Corp
11.11.1 Nipro Corp Company Details
11.11.2 Nipro Corp Business Overview
11.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Products and Services
11.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.11.5 Nipro Corp Recent Development
11.12 Vetter
11.12.1 Vetter Company Details
11.12.2 Vetter Business Overview
11.12.3 Vetter Contract Pharmaceutical Manufacturing Products and Services
11.12.4 Vetter Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.12.5 Vetter Recent Development
11.13 Sopharma
11.13.1 Sopharma Company Details
11.13.2 Sopharma Business Overview
11.13.3 Sopharma Contract Pharmaceutical Manufacturing Products and Services
11.13.4 Sopharma Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.13.5 Sopharma Recent Development
11.14 DPT Laboratories
11.14.1 DPT Laboratories Company Details
11.14.2 DPT Laboratories Business Overview
11.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Products and Services
11.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.14.5 DPT Laboratories Recent Development
11.15 Recipharm
11.15.1 Recipharm Company Details
11.15.2 Recipharm Business Overview
11.15.3 Recipharm Contract Pharmaceutical Manufacturing Products and Services
11.15.4 Recipharm Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.15.5 Recipharm Recent Development
11.16 NextPharma
11.16.1 NextPharma Company Details
11.16.2 NextPharma Business Overview
11.16.3 NextPharma Contract Pharmaceutical Manufacturing Products and Services
11.16.4 NextPharma Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.16.5 NextPharma Recent Development
11.17 Dishman
11.17.1 Dishman Company Details
11.17.2 Dishman Business Overview
11.17.3 Dishman Contract Pharmaceutical Manufacturing Products and Services
11.17.4 Dishman Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.17.5 Dishman Recent Development
11.18 Aesica
11.18.1 Aesica Company Details
11.18.2 Aesica Business Overview
11.18.3 Aesica Contract Pharmaceutical Manufacturing Products and Services
11.18.4 Aesica Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023)
11.18.5 Aesica Recent Development
12 Contract Pharmaceutical Manufacturing Market Dynamics
12.1 Contract Pharmaceutical Manufacturing Industry Trends
12.2 Contract Pharmaceutical Manufacturing Market Drivers
12.3 Contract Pharmaceutical Manufacturing Market Challenges
12.4 Contract Pharmaceutical Manufacturing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures
List of Tables
Table 1. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Key Players of API
Table 5. Key Players of Other
Table 6. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Contract Pharmaceutical Manufacturing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
Table 8. Global Contract Pharmaceutical Manufacturing Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Contract Pharmaceutical Manufacturing Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 10. Global Contract Pharmaceutical Manufacturing Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Table 11. Global Contract Pharmaceutical Manufacturing Revenue by Players (2018-2023) & (US$ Million)
Table 12. Global Contract Pharmaceutical Manufacturing Market Share by Players (2018-2023)
Table 13. Global Top Contract Pharmaceutical Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2022)
Table 14. Ranking of Global Top Contract Pharmaceutical Manufacturing Companies by Revenue (US$ Million) in 2022
Table 15. Global 5 Largest Players Market Share by Contract Pharmaceutical Manufacturing Revenue (CR5 and HHI) & (2018-2023)
Table 16. Global Key Players of Contract Pharmaceutical Manufacturing, Headquarters and Area Served
Table 17. Global Key Players of Contract Pharmaceutical Manufacturing, Product and Application
Table 18. Global Key Players of Contract Pharmaceutical Manufacturing, Date of Enter into This Industry
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Contract Pharmaceutical Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 21. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2018-2023)
Table 22. Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 23. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2024-2029)
Table 24. Global Contract Pharmaceutical Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 25. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2018-2023)
Table 26. Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 27. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2024-2029)
Table 28. North America Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023) & (US$ Million)
Table 29. North America Contract Pharmaceutical Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 30. North America Contract Pharmaceutical Manufacturing Revenue by Type (2024-2029) & (US$ Million)
Table 31. North America Contract Pharmaceutical Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 32. North America Contract Pharmaceutical Manufacturing Revenue by Application (2024-2029) & (US$ Million)
Table 33. North America Contract Pharmaceutical Manufacturing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Contract Pharmaceutical Manufacturing Revenue by Country (2018-2023) & (US$ Million)
Table 35. North America Contract Pharmaceutical Manufacturing Revenue by Country (2024-2029) & (US$ Million)
Table 36. Europe Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023) & (US$ Million)
Table 37. Europe Contract Pharmaceutical Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 38. Europe Contract Pharmaceutical Manufacturing Revenue by Type (2024-2029) & (US$ Million)
Table 39. Europe Contract Pharmaceutical Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 40. Europe Contract Pharmaceutical Manufacturing Revenue by Application (2024-2029) & (US$ Million)
Table 41. Europe Contract Pharmaceutical Manufacturing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2018-2023) & (US$ Million)
Table 43. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2024-2029) & (US$ Million)
Table 44. Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023) & (US$ Million)
Table 45. Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 46. Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Type (2024-2029) & (US$ Million)
Table 47. Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 48. Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Application (2024-2029) & (US$ Million)
Table 49. Asia-Pacific Contract Pharmaceutical Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 50. Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2018-2023) & (US$ Million)
Table 51. Asia Pacific Contract Pharmaceutical Manufacturing Revenue by Region (2024-2029) & (US$ Million)
Table 52. Latin America Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023) & (US$ Million)
Table 53. Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 54. Latin America Contract Pharmaceutical Manufacturing Revenue by Type (2024-2029) & (US$ Million)
Table 55. Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 56. Latin America Contract Pharmaceutical Manufacturing Revenue by Application (2024-2029) & (US$ Million)
Table 57. Latin America Contract Pharmaceutical Manufacturing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 58. Latin America Contract Pharmaceutical Manufacturing Revenue by Country (2018-2023) & (US$ Million)
Table 59. Latin America Contract Pharmaceutical Manufacturing Revenue by Country (2024-2029) & (US$ Million)
Table 60. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Company (2021-2023) & (US$ Million)
Table 61. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Type (2024-2029) & (US$ Million)
Table 63. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Application (2024-2029) & (US$ Million)
Table 65. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue by Country (2024-2029) & (US$ Million)
Table 68. Catalent Company Details
Table 69. Catalent Business Overview
Table 70. Catalent Contract Pharmaceutical Manufacturing Product and Services
Table 71. Catalent Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 72. Catalent Contract Pharmaceutical Manufacturing SWOT Analysis
Table 73. Catalent Recent Development
Table 74. DPx Company Details
Table 75. DPx Business Overview
Table 76. DPx Contract Pharmaceutical Manufacturing Product and Services
Table 77. DPx Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 78. DPx Contract Pharmaceutical Manufacturing SWOT Analysis
Table 79. DPx Recent Development
Table 80. Lonza Company Details
Table 81. Lonza Business Overview
Table 82. Lonza Contract Pharmaceutical Manufacturing Product and Services
Table 83. Lonza Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 84. Lonza Contract Pharmaceutical Manufacturing SWOT Analysis
Table 85. Lonza Recent Development
Table 86. Piramal Healthcare Company Details
Table 87. Piramal Healthcare Business Overview
Table 88. Piramal Healthcare Contract Pharmaceutical Manufacturing Product and Services
Table 89. Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 90. Piramal Healthcare Contract Pharmaceutical Manufacturing SWOT Analysis
Table 91. Piramal Healthcare Recent Development
Table 92. Aenova Company Details
Table 93. Aenova Business Overview
Table 94. Aenova Contract Pharmaceutical Manufacturing Product and Services
Table 95. Aenova Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 96. Aenova Contract Pharmaceutical Manufacturing SWOT Analysis
Table 97. Aenova Recent Development
Table 98. Jubilant Company Details
Table 99. Jubilant Business Overview
Table 100. Jubilant Contract Pharmaceutical Manufacturing Product and Services
Table 101. Jubilant Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 102. Jubilant Contract Pharmaceutical Manufacturing SWOT Analysis
Table 103. Jubilant Recent Development
Table 104. Famar Company Details
Table 105. Famar Business Overview
Table 106. Famar Contract Pharmaceutical Manufacturing Product and Services
Table 107. Famar Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 108. Famar Contract Pharmaceutical Manufacturing SWOT Analysis
Table 109. Famar Recent Development
Table 110. Boehringer Ingelheim Company Details
Table 111. Boehringer Ingelheim Business Overview
Table 112. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product and Services
Table 113. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 114. Boehringer Ingelheim Contract Pharmaceutical Manufacturing SWOT Analysis
Table 115. Boehringer Ingelheim Recent Development
Table 116. Fareva Holding Company Details
Table 117. Fareva Holding Business Overview
Table 118. Fareva Holding Contract Pharmaceutical Manufacturing Product and Services
Table 119. Fareva Holding Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 120. Fareva Holding Contract Pharmaceutical Manufacturing SWOT Analysis
Table 121. Fareva Holding Recent Development
Table 122. AbbVie Company Details
Table 123. AbbVie Business Overview
Table 124. AbbVie Contract Pharmaceutical Manufacturing Product and Services
Table 125. AbbVie Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 126. AbbVie Contract Pharmaceutical Manufacturing SWOT Analysis
Table 127. AbbVie Recent Development
Table 128. Nipro Corp Company Details
Table 129. Nipro Corp Business Overview
Table 130. Nipro Corp Contract Pharmaceutical Manufacturing Product and Services
Table 131. Nipro Corp Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 132. Nipro Corp Recent Development
Table 133. Vetter Company Details
Table 134. Vetter Business Overview
Table 135. Vetter Contract Pharmaceutical Manufacturing Product and Services
Table 136. Vetter Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 137. Vetter Recent Development
Table 138. Sopharma Company Details
Table 139. Sopharma Business Overview
Table 140. Sopharma Contract Pharmaceutical Manufacturing Product and Services
Table 141. Sopharma Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 142. Sopharma Recent Development
Table 143. DPT Laboratories Company Details
Table 144. DPT Laboratories Business Overview
Table 145. DPT Laboratories Contract Pharmaceutical Manufacturing Product and Services
Table 146. DPT Laboratories Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 147. DPT Laboratories Recent Development
Table 148. Recipharm Company Details
Table 149. Recipharm Business Overview
Table 150. Recipharm Contract Pharmaceutical Manufacturing Product and Services
Table 151. Recipharm Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 152. Recipharm Recent Development
Table 153. NextPharma Company Details
Table 154. NextPharma Business Overview
Table 155. NextPharma Contract Pharmaceutical Manufacturing Product and Services
Table 156. NextPharma Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 157. NextPharma Recent Development
Table 158. Dishman Company Details
Table 159. Dishman Business Overview
Table 160. Dishman Contract Pharmaceutical Manufacturing Product and Services
Table 161. Dishman Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 162. Dishman Recent Development
Table 163. Aesica Company Details
Table 164. Aesica Business Overview
Table 165. Aesica Contract Pharmaceutical Manufacturing Product and Services
Table 166. Aesica Contract Pharmaceutical Manufacturing Revenue in Contract Pharmaceutical Manufacturing Business (2018-2023) & (US$ Million)
Table 167. Aesica Recent Development
Table 168. Contract Pharmaceutical Manufacturing Market Trends
Table 169. Contract Pharmaceutical Manufacturing Market Drivers
Table 170. Contract Pharmaceutical Manufacturing Market Challenges
Table 171. Contract Pharmaceutical Manufacturing Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Contract Pharmaceutical Manufacturing Product Picture
Figure 2. Global Contract Pharmaceutical Manufacturing Market Size by Type (US$ Million): 2018 VS 2022 VS 2029
Figure 3. Global Contract Pharmaceutical Manufacturing Market Share by Type: 2022 VS 2029
Figure 4. Oral Features
Figure 5. Injectable Features
Figure 6. API Features
Figure 7. Other Features
Figure 8. Global Contract Pharmaceutical Manufacturing Market Size by Application (US$ Million): 2018 VS 2022 VS 2029
Figure 9. Global Contract Pharmaceutical Manufacturing Market Share by Application: 2022 VS 2029
Figure 10. Large Enterprise
Figure 11. Small Medium Enterprise
Figure 12. Contract Pharmaceutical Manufacturing Report Years Considered
Figure 13. Global Contract Pharmaceutical Manufacturing Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Contract Pharmaceutical Manufacturing Market Size 2018-2029 (US$ Million)
Figure 15. Global Contract Pharmaceutical Manufacturing Market Size Market Share by Region: 2022 VS 2029
Figure 16. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Region in 2018 VS 2022
Figure 17. Global Contract Pharmaceutical Manufacturing Revenue Market Share Forecast by Region (2024-2029)
Figure 18. Global Top 10 Contract Pharmaceutical Manufacturing Countries Ranking by Market Size (US$ Million) in 2022
Figure 19. Global Contract Pharmaceutical Manufacturing Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Figure 20. Global Contract Pharmaceutical Manufacturing Market Share by Players in 2022
Figure 21. Global Top Contract Pharmaceutical Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Contract Pharmaceutical Manufacturing Revenue in 2022
Figure 23. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Company in 2022
Figure 24. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2018-2029)
Figure 25. North America Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2018-2029)
Figure 26. North America Contract Pharmaceutical Manufacturing Revenue Share by Country (2018-2029)
Figure 27. U.S. Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 28. Canada Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 29. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Company in 2022
Figure 30. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2018-2029)
Figure 31. Europe Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2018-2029)
Figure 32. Europe Contract Pharmaceutical Manufacturing Revenue Share by Country (2018-2029)
Figure 33. Germany Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 34. France Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 35. U.K. Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 36. Italy Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 37. Russia Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Company in 2022
Figure 39. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2018-2029)
Figure 40. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2018-2029)
Figure 41. Asia Pacific Contract Pharmaceutical Manufacturing Revenue Share by Region (2018-2029)
Figure 42. China Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 43. Japan Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 44. South Korea Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 45. India Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 46. Australia Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 47. China Taiwan Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 48. Indonesia Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 49. Thailand Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 50. Malaysia Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 51. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Company in 2022
Figure 52. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2018-2029)
Figure 53. Latin America Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2018-2029)
Figure 54. Latin America Contract Pharmaceutical Manufacturing Revenue Share by Country (2018-2029)
Figure 55. Mexico Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 56. Brazil Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 57. Argentina Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 58. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Company in 2022
Figure 59. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Contract Pharmaceutical Manufacturing Revenue Share by Country (2018-2029)
Figure 62. Turkey Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 63. Saudi Arabia Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 64. UAE Contract Pharmaceutical Manufacturing Revenue (2018-2029) & (US$ Million)
Figure 65. Catalent Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 66. DPx Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 67. Lonza Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 68. Piramal Healthcare Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 69. Aenova Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 70. Jubilant Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 71. Famar Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 72. Boehringer Ingelheim Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 73. Fareva Holding Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 74. AbbVie Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 75. Nipro Corp Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 76. Vetter Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 77. Sopharma Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 78. DPT Laboratories Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 79. Recipharm Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 80. NextPharma Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 81. Dishman Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 82. Aesica Revenue Growth Rate in Contract Pharmaceutical Manufacturing Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
